PRT3789
PRT3789-01
Phase 2 small_molecule completed
Quick answer
PRT3789 for Advanced Solid Tumor is a Phase 2 program (small_molecule) at Prelude Therapeutics Inc with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Prelude Therapeutics Inc
- Indication
- Advanced Solid Tumor
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed